Yield10 Bioscience
company
About
Metabolix offers sustainable solutions for the plastics, chemicals and energy industries.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $6M
- Industries
- Biotechnology,Chemical,Energy
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$18.70M
Yield10 Bioscience has raised a total of
$18.70M
in funding over 2 rounds. Their latest funding was raised on
Jan 31, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 31, 2021 | Post-IPO Equity | $12.70M | 1 |
|
— | Detail |
| May 5, 2011 | Grant | $6M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Yield10 Bioscience is funded by 2 investors.
Jack W. Schuler Living Trust
and US Department of Energy
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Equity |
US Department of Energy
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
